ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE
ADVANCES IN OPTICS FOR BIOTECHNOLOGY, MEDICINE
批准号:
6941062
负责人:
VASILIS NTZIACHRISTOS
金额:
$0.8万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-18 至 2006-06-30
中文摘要
描述(由申请人提供):生物技术,医学和外科光学进展是一个小型(约100-120名参与者),跨学科会议,重点是生物医学光学-与美国国立卫生研究院直接相关的领域。 这次会议的大部分内容都是针对成像,检测和治疗疾病,包括癌症和癌前病变的新型光学技术。 光子学,光的科学和工程,被广泛认为是下一次技术革命的引擎,它的影响也开始在生物医学科学中感受到。 从显微镜到非侵入性诊断再到遗传分析,光学为探测细胞、组织和生物体提供了高度特异性的方法。 这是一门高度跨学科的科学,这种材料的开发和传播可以影响医疗保健,提高诊断和治疗效果,降低成本,减少诊断程序的侵入性,更好地了解组织的变化,并最终改善医疗保健。 这次会议是一个工具,以促进必要的跨学科的互动,看到的想法带来的成果,作为实用的技术和设备。 这个特殊的场所传统上包括高影响力的邀请会谈,重点是适应这个高度发展的领域的关键领域。 这次会议的主要目的是:
目标1:识别并汇集生物光学领域最有前途的技术和科学家,并介绍和理解最先进的方法。
目的2:确定这些技术在基础研究、临床实践、药物发现和医疗保健中的应用进展。
目标3:邀请传统生物光学圈以外的主要关键领域的领先科学家介绍新的需求和应用。
目标4:促进受邀科学家和参与学生之间的互动,支持生物光学和相关应用的多学科领域的教育和理解,并实现合作。
英文摘要
DESCRIPTION (provided by applicant): Advances in Optics for Biotechnology, Medicine and Surgery is a small (approximately 100-120 participants), interdisciplinary conference focused on biomedical optics - an area of direct relevance to the National Institutes of Health. Much of this conference is geared to novel optical technologies for imaging, detection and treatment of disease, including cancers and pre-cancers. Photonics, the science and engineering of light, is widely regarded as the engine of the next technical revolution and its influence is also beginning to be felt in biomedical sciences. From microscopy to noninvasive diagnostics to genetic analysis, optics offers highly specific ways to probe cells, tissues, and living organisms. This is a highly interdisciplinary science and the development and dissemination of this material can impact medical care and improve diagnostic and treatment efficacy, reduce cost, reduce invasiveness of diagnostic procedures, better understand changes in tissue, and ultimately improve healthcare. This conference is a vehicle to facilitate the interdisciplinary interaction necessary to see ideas brought to fruition as practical techniques and devices. This particular venue traditionally encompasses high impact invited talks, focused on key areas that adapt to this highly evolving field. The main aims of this conference are:
Aim 1: To identify and bring together the most promising technologies and scientists in bio-optics and enable presentation and understanding of the key state of the art methods.
Aim 2: To ascertain the progress with application of these technologies into basic research, clinical practice and in drug discovery and healthcare.
Aim 3: To invite leading scientists in key major fields outside the traditional bio-optics circle to introduce novel needs and applications.
Aim 4: To promote interaction between the invited scientists and participating students, to support education and understanding of the multi-disciplinary field of bio-optics and associated applications and to enable collaborations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Whole body tomography of fluorescent proteins in vivo
-
批准号:7318504
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2007
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
Whole body tomography of fluorescent proteins in vivo
-
批准号:7488838
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2007
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
Hybrid Complete Protection Flourescence Molecular Tomography and X-ray CT
-
批准号:7133361
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2006
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
Hybrid optical-ultrasound scanner for cancer imaging
-
批准号:6829849
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2004
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
Hybrid optical-ultrasound scanner for cancer imaging
-
批准号:6918685
-
项目类别:
-
资助金额:$20.11万
-
财政年份:2004
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
3D Time Domain Molecular Imaging
-
批准号:6588933
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2002
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
3D Time Domain Molecular Imaging
-
批准号:6791256
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2002
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
3D Time Domain Molecular Imaging
-
批准号:6659790
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2002
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
3D Time Domain Molecular Imaging
-
批准号:6937669
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2002
-
负责人:VASILIS NTZIACHRISTOS
-
依托单位:
海外基金